Stop TB Working Group on MDR-TB - Meetings
6th Meeting of the Stop TB Working Group on MDR-TB, Tbilisi, Georgia
The sixth meeting of the Working Group on MDR-TB of the Stop TB Partnership (WG) was held from 20 to 22 September in Tbilisi, Georgia. More than 170 participants attended the meeting, representing countries, bilateral and multilateral agencies, international organizations, nongovernmental organizations, pharmaceutical industries and universities. Overall, the WG meeting took stock of lessons learned on the six major hurdles to scale up management of MDR-TB worldwide (management of second-line anti-TB drugs, laboratory capacity, community involvement, recording and reporting, infection control and planning of scale up).
Presentations
Day 1
01 Form Dream to Reality Raviglione- 02 Global MDR-TB and XDR-TB response Plan Kimmerling
- 03 Challenge of Scale-up Nunn
04 Case Gordon - Video- 05 Scaling-up MDR-TB Management Salakaia
06 Almacen- 06 Philippines MDR TB Scale up QUELAPIO
- 07 Management of Second Line Drugs Jaime Bayona
- 08 Management of Second Line Drugs - Prof Erokhin, Russia
- 09 Building lab capacity to deal with MDR-TB Paramasivan
- 10 Building lab capacity to deal with MDR-TB Varaine
- 11 Building lab capacity to deal with MDR-TB. Moselinyane Letsie
- 12 TB Infection Control Miller
- 13 TB Infection Control Yagui
- 14 TB Infection Control no longer neglected Paul Jensen
Day 2
- 01 Scaling-up patient and community participation Philippines Quelapio
- 02 Scaling-up patient and community participation N. Tarenec
- 03 Recording and Reporting in MDR-TB Heldal
- 04 Recording and Reporting in MDR-TB Rodriguez
- 05 Lilly MDRTB Partnership - 1_Patrizia Carlevaro
- 05 Lilly MDRTB Partnership - 2_EJaramillo Lilly and WHO in Georgia 09 07
- 05 Lilly MDRTB Partnership - 3_Uta Grosse
- 05 Lilly MDRTB Partnership - 4_Lasha Goguadze
- 05 Lilly MDRTB Partnership - 5_KESHAVJEE
- 06 Update on Drug Resistance Surveillance Wright
- 07 Updated WHO guidelines Weyer
- 08 MDR-TB under the media spotlight - Thomas
- 09 GLC Progress report Weyer
- 10 Research on DR-TB Cobelens
- 11 Management of 2nd line anti-TB drugs Matiru
- 12 Lab Strengthening Ridderhof
- 13 Advocacy and social mobilization on MDR-TB Schiegg
- 14 TB Infection control Miller
Day 3
Disclaimer:
The presentations outlined herein contain the collective views of the Working Group on MDR-TB of the Stop TB Partnership and does not necessarily represent the decisions or the stated policy of the World Health Organization and Stop TB Partnership.
Meeting Report
Final Agenda
Interviews
Photos
(This file is quite large and may take some time to download.)Related links
Stop TB Working Group on DOTS-Plus for MDR-TB, Atlanta, USA, 12 May 2006
Atlanta meeting report.pdf
Joint Meeting of the DOTS Expansion, TB/HIV and DOTS-Plus for MDR-TB Working Groups in Memory of Lisa Véron, Versailles and Paris, 15-18 October 2005
http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006_366_eng.pdf
Stop TB Working Group on DOTS-Plus for MDR-TB, Paris, France 27-28 October 2003, WHO/HTM/TB/2004.341 [pdf 341kb]
DOTS-Plus: preliminary results and emerging issues. Proceedings of the Meeting of the Stop TB Working Group on DOTS-Plus for MDR-TB, Tallinn, Estonia, 10-12 April 2002. WHO/CDS/TB/2002.307 [pdf 2mb]
Progress in DOTS-Plus and the Management of Multidrug-Resistant Tuberculosis (MDR-TB). Proceedings of the Meeting of the Stop TB Working Group on DOTS-Plus for MDR-TB, Lima, Peru, 25-27 January 2001. WHO/CDS/TB/2001.292 [pdf 2mb]